44
In band
Moving averages
SMA 200$467.58+10.06%
Company profile
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$130.56B
P/E ratio29.98
EPS$17.19
Beta0.32
Dividend yield0.00%
52-week high$560.25
52-week low$374.17
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 48
CRSP
CRISPR Therapeutics AG
RSI 44
IOVA
Iovance Biotherapeutics Inc
RSI 69
MRNA
Moderna Inc
RSI 62
VKTX
Viking Therapeutics Inc
RSI 40
SRPT
Sarepta Therapeutics Inc
RSI 55
EDIT
Editas Medicine Inc
RSI 43
NVAX
Novavax Inc
RSI 57
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 46
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 53
RSI alerts for VRTX
Get an email the moment Vertex Pharmaceuticals Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 1:55 AM EDT